The US Food and Drug Administration (FDA) has awarded regulatory clearance for the Arcuro Medical’s (Arcuro) SuperBall meniscus repair system.

A Trendlines Group portfolio company, Arcuro Medical has developed the all-suture meniscus repair system to maintain knee functionality.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Recently, the company also secured patent for this system in the US.

“Arcuro expects that this easy-to-use system will enable the surgeons to repair the meniscus instead of removing it.”

Arcuro CEO Lee Ranon said: “We are very excited to have achieved FDA clearance in addition to the news of receiving our US patent.

“These two important milestones will enable the company to begin its clinical evaluation phase straight away.”

Meniscus tears are common among various population groups but are predominant among sportspersons, ageing people or patients with cartilage problems.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The standard treatment avoids the removal of the meniscus and involves arthroscopic repair techniques, which may result in rigid implants and inconvenient delivery systems.

It may also lead to long-term damage to the meniscus, poor repair and higher chances of intraoperative failure.

Stated to be secure and effective, the SuperBall meniscus repair system underwent a series of pre-clinical studies in the US and Israel.

Arcuro expects that this easy-to-use system will enable the surgeons to repair the meniscus instead of removing it.

The Trendlines Group chairman and CEO Steve Rhodes said: “We are very proud of the progress that the Arcuro team has made towards bringing their SuperBall meniscus repair system to market.

“We look forward to following their progress in improving patient outcomes and reducing surgeries in a market seeking a solution to this common and painful problem.”

Arcuro has already submitted a patent application at national phase in China, Israel and Europe.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact